Morgan Stanley
CELG

Morgan Stanley’s Celgene Corp CELG Stock Holding History

Morgan Stanley’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,666,105
Closed -$165M – 7004
2019
Q3 		$165M Sell
1,666,105
-432,991
-21% -$41.1M 0.04% 395
2019
Q2 		$194M Sell
2,099,096
-685,386
-25% -$65.1M 0.05% 350
2019
Q1 		$263M Sell
2,784,482
-922,804
-25% -$80.7M 0.07% 277
2018
Q4 		$238M Buy
3,707,286
+470,963
+15% +$34.8M 0.07% 283
2018
Q3 		$290M Buy
3,236,323
+549,404
+20% +$48.6M 0.07% 270
2018
Q2 		$213M Sell
2,686,919
-777,078
-22% -$64.5M 0.06% 325
2018
Q1 		$309M Sell
3,463,997
-43,147
-1% -$4.14M 0.09% 239
2017
Q4 		$366M Sell
3,507,144
-571,519
-14% -$64.5M 0.1% 209
2017
Q3 		$595M Buy
4,078,663
+69,914
+2% +$9.52M 0.18% 124
2017
Q2 		$521M Buy
4,008,749
+22,586
+0.6% +$2.77M 0.16% 149
2017
Q1 		$496M Buy
3,986,163
+84,933
+2% +$10.2M 0.15% 142
2016
Q4 		$452M Sell
3,901,230
-794,964
-17% -$88.5M 0.15% 148
2016
Q3 		$491M Buy
4,696,194
+247,342
+6% +$26.8M 0.17% 130
2016
Q2 		$439M Buy
4,448,852
+26,046
+0.6% +$2.69M 0.16% 144
2016
Q1 		$443M Buy
4,422,806
+539,502
+14% +$55.6M 0.17% 138
2015
Q4 		$465M Buy
3,883,304
+284,929
+8% +$33M 0.17% 142
2015
Q3 		$389M Sell
3,598,375
-4,306
-0.1% -$534K 0.14% 161
2015
Q2 		$417M Sell
3,602,681
-469,539
-12% -$53.7M 0.14% 165
2015
Q1 		$469M Sell
4,072,220
-344,067
-8% -$41.1M 0.17% 139
2014
Q4 		$494M Buy
4,416,287
+454,661
+11% +$48M 0.18% 125
2014
Q3 		$375M Buy
3,961,626
+421,440
+12% +$38M 0.14% 166
2014
Q2 		$304M Sell
3,540,186
-349,558
-9% -$26.6M 0.12% 202
2014
Q1 		$272M Sell
3,889,744
-696,556
-15% -$55.2M 0.11% 210
2013
Q4 		$387M Buy
4,586,300
+873,512
+24% +$69.1M 0.16% 147
2013
Q3 		$286M Sell
3,712,788
-336,928
-8% -$23.6M 0.14% 176
2013
Q2 		$237M Buy
+4,049,716
New +$244M 0.12% 206

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Morgan Stanley's CELG Position: Q4 2019 in Review

Morgan Stanley sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,666,105 shares — an estimated $165M sold.

Morgan Stanley first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $595M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Morgan Stanley reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Morgan Stanley sold 1,666,105 Celgene Corp shares in Q4 2019, an estimated $165M.
  • Morgan Stanley first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Morgan Stanley's Celgene Corp position peaked at $595M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.